Studies Linking GLP-1 Medications to NAION Several peer-reviewed studies have confirmed an increased risk of NAION in patients taking GLP-1 drugs: Harvard Medical School & Mass General Brigham Study (JAMA Ophthalmology, 2024) 9% of diabetic patients taking semaglutide developed NAION, compared to 1.8% on other diabetes drugs (a 4-fold increased risk)
Long-term anti-aging: The combination supports skin elasticity, collagen production, cellular repair, and overall vitality at the systemic level
Ipamorelin is classified as a Growth Hormone-Releasing Peptide (GHRP), recognized for its capacity to increase levels of growth hormone
Consider alternatives
readers are encouraged to check these sources for the most up-to-date information, as the development programme is ongoing
Whether youre recovering from a flare-up or rethinking your routine entirely, our line was made to help you calm inflammation, repair damage, and glow with confidence